DeSci

DeSci

Feb 25, 2025

Decentralized Platforms Upending How Synthetic Biology is Done

Decentralized science platforms are allowing researchers to fund, conduct, and publish their research over the blockchain

DeSci

Driving AI and SynBio Breakthroughs, NSF Funds $15M iBioFoundry

DeSci

Driving AI and SynBio Breakthroughs, NSF Funds $15M iBioFoundry

DeSci

Biomatter Raises €6.5M to Revolutionize Enzyme Design with Generative AI

DeSci

Biomatter Raises €6.5M to Revolutionize Enzyme Design with Generative AI

DeSci

bit.bio Welcomes New CFO to Drive Financial Strategy and Growth

DeSci

bit.bio Welcomes New CFO to Drive Financial Strategy and Growth

DeSci

SNIPR Biome Secures Gates Foundation Funding to Combat Environmental Enteric Dysfunction in Pregnant Women

DeSci

SNIPR Biome Secures Gates Foundation Funding to Combat Environmental Enteric Dysfunction in Pregnant Women

SynBioBeta

2027

May 3-6,

2027

San Jose Convention Center ·

CA, USA

Event Details

Newsletter

Join List

More Insights

More Insights

More Insights

DeSci

Nuclera Secures £1.14M in Innovate UK Grants to Enhance Protein Expression Technology

DeSci

Nuclera Secures £1.14M in Innovate UK Grants to Enhance Protein Expression Technology

DeSci

The UK’s Science and Technology Secretary announces £100M Engineering Biology investment

DeSci

The UK’s Science and Technology Secretary announces £100M Engineering Biology investment

DeSci

AVANT BIO Takes Center Stage as Premier Equity Firm in Life Sciences, Tech Bio, and HealthTech

DeSci

AVANT BIO Takes Center Stage as Premier Equity Firm in Life Sciences, Tech Bio, and HealthTech

DeSci

Elegen and GSK Forge Strategic Partnership to Advance Cell-Free DNA Production Technology

DeSci

Elegen and GSK Forge Strategic Partnership to Advance Cell-Free DNA Production Technology

DeSci

Innovation in Bloom: Cambrium’s €8 Million Seed to Sow Sustainable Molecules

DeSci

Innovation in Bloom: Cambrium’s €8 Million Seed to Sow Sustainable Molecules

DeSci

VitaDAO's Digital Democracy: Greenlighting Their First Biotech Venture

DeSci

VitaDAO's Digital Democracy: Greenlighting Their First Biotech Venture

DeSci

Arzeda Partnership Looks to Revolutionize the Future of Designer Proteins

DeSci

Arzeda Partnership Looks to Revolutionize the Future of Designer Proteins

DeSci

Amyris Files For Bankruptcy as Part of Its Strategic Transformation Plan

DeSci

Amyris Files For Bankruptcy as Part of Its Strategic Transformation Plan

DeSci

Illumina CEO Francis deSouza Resigns Amid Controversial Grail Acquisition

DeSci

Illumina CEO Francis deSouza Resigns Amid Controversial Grail Acquisition

DeSci

Telesis Bio Captures $28M in Financing, $46.2M Available With Warrant Exercise

DeSci

Telesis Bio Captures $28M in Financing, $46.2M Available With Warrant Exercise

DeSci

Nalu Bio Announces a $12M Series A to Set a Higher Standard for Cannabinoid Production

DeSci

Nalu Bio Announces a $12M Series A to Set a Higher Standard for Cannabinoid Production

DeSci

BiomX Announces $7.5 Million Private Placement

DeSci

BiomX Announces $7.5 Million Private Placement

DeSci

Robigo Secures $7M Seed Round to Protect Crops from Untreatable Diseases

DeSci

Robigo Secures $7M Seed Round to Protect Crops from Untreatable Diseases

DeSci

Checkerspot Closes $55 Million Series C to Bring the Bioeconomy to Your Doorstep

DeSci

Checkerspot Closes $55 Million Series C to Bring the Bioeconomy to Your Doorstep

DeSci

Slingshot Biosciences Announces $11 Million in Series A3 Financing

DeSci

Slingshot Biosciences Announces $11 Million in Series A3 Financing

DeSci

CRISPR QC Closes Seed Round at $1.6M and Appoints George Bonaros to Board of Directors to Fuel Commercial Growth of Their CRISPR Analytics Platform

DeSci

CRISPR QC Closes Seed Round at $1.6M and Appoints George Bonaros to Board of Directors to Fuel Commercial Growth of Their CRISPR Analytics Platform

DeSci

Ganymede Bio, the Cloud Provider Purpose-Built for the Life Sciences and Manufacturing Industries, Raises $12.75 Million in Series A Funding

DeSci

Ganymede Bio, the Cloud Provider Purpose-Built for the Life Sciences and Manufacturing Industries, Raises $12.75 Million in Series A Funding

DeSci

Danish synthetic biology company Octarine Bio closes €2M fundraising co-led by DSM Venturing and Oskare Capital

DeSci

Danish synthetic biology company Octarine Bio closes €2M fundraising co-led by DSM Venturing and Oskare Capital

DeSci

Carver Biosciences Launches with Seed Financing to Advance CRISPR/Cas13-based Technologies

DeSci

Carver Biosciences Launches with Seed Financing to Advance CRISPR/Cas13-based Technologies

DeSci

Arsenal Biosciences Closes $220 Million Series B Financing to Advance Programmable Cell Therapy Programs into Clinical Development

DeSci

Arsenal Biosciences Closes $220 Million Series B Financing to Advance Programmable Cell Therapy Programs into Clinical Development

DeSci

Bluestem Biosciences, a Sustainable Chemicals Startup, Closes $5 Million Pre-Seed Funding to Scale Discovery Through Industrial Anaerobic Fermentation

DeSci

Bluestem Biosciences, a Sustainable Chemicals Startup, Closes $5 Million Pre-Seed Funding to Scale Discovery Through Industrial Anaerobic Fermentation

DeSci

Genoa Ventures Announces Second Fund to Expand Investing in the Convergence of Biology and Technology

DeSci

Genoa Ventures Announces Second Fund to Expand Investing in the Convergence of Biology and Technology

DeSci

Biosyntia closes a 11.5 million EUR round to launch world’s first bio-based vitamin B7

DeSci

Biosyntia closes a 11.5 million EUR round to launch world’s first bio-based vitamin B7

DeSci

Precision BioSciences Announces $50 Million Offering of Common Stock

DeSci

Precision BioSciences Announces $50 Million Offering of Common Stock

DeSci

Houston-Based SynBio VC Firm Grows Advisory Team with Two New Experts

DeSci

Houston-Based SynBio VC Firm Grows Advisory Team with Two New Experts

DeSci

Reverie Labs Raises $25M Series A Round to Broaden Impact of its Computational Kinase Drug Discovery Platform

DeSci

Reverie Labs Raises $25M Series A Round to Broaden Impact of its Computational Kinase Drug Discovery Platform

DeSci

Germin8 Ventures Names Dr. Ashlie L. Burkart as Chief Scientific Officer

DeSci

Germin8 Ventures Names Dr. Ashlie L. Burkart as Chief Scientific Officer

DeSci

Earli Raises $40 Million Series A Funding Led by Khosla Ventures

DeSci

Earli Raises $40 Million Series A Funding Led by Khosla Ventures

DeSci

Gamida Cell Announces Closing of $75 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

DeSci

Gamida Cell Announces Closing of $75 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

DeSci

Codexis and Casdin Capital Launch SynBio Innovation Accelerator

DeSci

Codexis and Casdin Capital Launch SynBio Innovation Accelerator

DeSci

Twist Bioscience Announces Completion of $50 Million Registered Direct Offering Priced At-The-Market

DeSci

Twist Bioscience Announces Completion of $50 Million Registered Direct Offering Priced At-The-Market

DeSci

Science Exchange Raises Capital to Advance Innovative Outsourced R&D Platform to Drive Biopharma Productivity

DeSci

Science Exchange Raises Capital to Advance Innovative Outsourced R&D Platform to Drive Biopharma Productivity

DeSci

Intrexon Reports Second Quarter and First Half 2019 Financial Results

DeSci

Intrexon Reports Second Quarter and First Half 2019 Financial Results

DeSci

CB Therapeutics Announces Closing of the Latest Round of Equity Funding for Scaling Up Biosynthesis Research and Production

DeSci

CB Therapeutics Announces Closing of the Latest Round of Equity Funding for Scaling Up Biosynthesis Research and Production

DeSci

News digest #254 - These 98 synthetic biology companies raised $3.8 billion in 2018

DeSci

News digest #254 - These 98 synthetic biology companies raised $3.8 billion in 2018

DeSci

Digest #253 - $1.2 billion in 1 week: Moderna $604M IPO, Zymergen $400M, Synthorx $131M IPO, Synthace $25.6M, Elemental Machines $9M, GenEdit $8.5M + our early bird ends Friday!

DeSci

Digest #253 - $1.2 billion in 1 week: Moderna $604M IPO, Zymergen $400M, Synthorx $131M IPO, Synthace $25.6M, Elemental Machines $9M, GenEdit $8.5M + our early bird ends Friday!

DeSci

News Digest #243 – SynBioBeta Day 3, Twist $86.3M IPO, Pivot Bio’s $70M, Genomatica’s $90M

DeSci

News Digest #243 – SynBioBeta Day 3, Twist $86.3M IPO, Pivot Bio’s $70M, Genomatica’s $90M

DeSci

News Digest #242 – Download our program guide, Sutro’s IPO + 14 awesome workshops. (sponsored by Synthego)

DeSci

News Digest #242 – Download our program guide, Sutro’s IPO + 14 awesome workshops. (sponsored by Synthego)

DeSci

News Digest #229 – $85.4 m for Sutro, $23 m for Mammoth Biosciences, Peter Thiel + Wild Earth, CRISPR crops hurdles and space bioprinters (sponsored by the Open Philanthropy Project)

DeSci

News Digest #229 – $85.4 m for Sutro, $23 m for Mammoth Biosciences, Peter Thiel + Wild Earth, CRISPR crops hurdles and space bioprinters (sponsored by the Open Philanthropy Project)

DeSci

News Digest #225 - SynBio Q2 funding tops $925m, today’s SynbiCITE webinar & John Oliver on gene editing

DeSci

News Digest #225 - SynBio Q2 funding tops $925m, today’s SynbiCITE webinar & John Oliver on gene editing

DeSci

News Digest #224 – Join us live at Amyris today, Early bird ends Friday + 5 companies raise $278M

DeSci

News Digest #224 – Join us live at Amyris today, Early bird ends Friday + 5 companies raise $278M

DeSci

News Digest #206 – Senti Bio Raises $53M, Inscripta $55.5M, Perfect Day $24.7M, Prokarium $10M, Boost Biomes $2M

DeSci

News Digest #206 – Senti Bio Raises $53M, Inscripta $55.5M, Perfect Day $24.7M, Prokarium $10M, Boost Biomes $2M

DeSci

News Digest #202 – $12.3M for Evonetix and $10M for Engine Bio, SynBioBeta Early Bird ends today!

DeSci

News Digest #202 – $12.3M for Evonetix and $10M for Engine Bio, SynBioBeta Early Bird ends today!

DeSci

Intrexon Announces Closing of Public Offering of Common Stock and Exercise of Option by Underwriters

DeSci

Intrexon Announces Closing of Public Offering of Common Stock and Exercise of Option by Underwriters

DeSci

News Digest #197 - These Fifty Synthetic Biology Companies Raised $1.7B in 2017

DeSci

News Digest #197 - These Fifty Synthetic Biology Companies Raised $1.7B in 2017

DeSci

These Fifty Synthetic Biology Companies Raised $1.7B in 2017

DeSci

These Fifty Synthetic Biology Companies Raised $1.7B in 2017

DeSci

Intrexon Corporation Enters into $100 Million Preferred Stock Equity Facility

DeSci

Intrexon Corporation Enters into $100 Million Preferred Stock Equity Facility

DeSci

Three New Mega-Raises Put SynBio on Track for Record-Breaking Year of Funding

DeSci

Three New Mega-Raises Put SynBio on Track for Record-Breaking Year of Funding